Comparative Pharmacology
Head-to-head clinical analysis: COBAVITE versus DODEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COBAVITE versus DODEX.
COBAVITE vs DODEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cobavite is a combination of vitamin B12 and intrinsic factor; vitamin B12 is essential for DNA synthesis, hematopoiesis, and neurological function. Intrinsic factor facilitates the absorption of vitamin B12 in the ileum.
Hydroxocobalamin is a synthetic form of vitamin B12, which acts as a cofactor for methionine synthase and methylmalonyl-CoA mutase, essential for DNA synthesis, myelin formation, and hematopoiesis.
1.5 mg/kg IV every 12 hours
1 mg intramuscularly once every 7-10 days for maintenance; 1 mg intramuscularly once daily for 7 days for initial treatment.
None Documented
None Documented
Terminal half-life 12-15 hours in healthy adults; prolonged to 24-30 hours in severe renal impairment (CrCl <30 mL/min).
Terminal elimination half-life is approximately 6 days (range 4-10 days) in plasma; however, due to extensive tissue binding and enterohepatic recirculation, the pharmacodynamic half-life for correction of deficiency is about 1 year.
Renal excretion of unchanged drug 60-70%; biliary/fecal elimination 20-30%; minor hepatic metabolism.
Primarily renal: ~50-80% of absorbed dose excreted unchanged in urine via glomerular filtration. Biliary/fecal excretion accounts for <10% as cyanocobalamin.
Category C
Category C
Vitamin B12 Supplement
Vitamin B12 Supplement